OSTEONIC Past Earnings Performance
Past criteria checks 2/6
OSTEONIC has been growing earnings at an average annual rate of 337.8%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 40.1% per year. OSTEONIC's return on equity is 7.1%, and it has net margins of 13.2%.
Key information
337.8%
Earnings growth rate
286.7%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 40.1% |
| Return on equity | 7.1% |
| Net Margin | 13.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How OSTEONIC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 27,799 | 3,658 | 6,262 | 1,254 |
| 30 Sep 23 | 25,973 | 470 | 5,766 | 586 |
| 30 Jun 23 | 24,342 | -452 | 5,740 | 458 |
| 31 Mar 23 | 22,131 | -171 | 5,455 | 484 |
| 31 Dec 22 | 19,839 | 836 | 4,926 | 454 |
| 30 Sep 22 | 18,116 | 2,345 | 5,760 | 297 |
| 30 Jun 22 | 17,269 | 2,264 | 5,492 | 302 |
| 31 Mar 22 | 16,338 | -70 | 5,629 | 267 |
| 31 Dec 21 | 15,598 | -2,852 | 5,062 | 256 |
Quality Earnings: A226400 has a large one-off loss of ₩504.1M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: A226400's current net profit margins (13.2%) are higher than last year (4.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A226400's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A226400's past year earnings growth to its 5-year average.
Earnings vs Industry: A226400 earnings growth over the past year (337.8%) exceeded the Medical Equipment industry 8.8%.
Return on Equity
High ROE: A226400's Return on Equity (7.1%) is considered low.